Headache drug wars

3:45 PM ET Mon, 28 March 2016

CNBC's Meg Tirrell reports on Alder Biopharmaceuticals' chronic migraine drug trial and how other pharma companies are developing new treatments and therapies, as well as the latest on Valeant CEO Mike Pearson's subpoena.